Published online Mar 25, 2024. doi: 10.5527/wjn.v13.i1.88028
Peer-review started: September 6, 2023
First decision: November 21, 2023
Revised: November 30, 2023
Accepted: January 11, 2024
Article in press: January 11, 2024
Published online: March 25, 2024
Processing time: 197 Days and 14.7 Hours
The classification of focal segmental glomerulosclerosis (FSGS) is controversial and challenging. There is still a lack of a unified and consensus-based approach to classify this disease, which will be both practical and clinically useful.
This study addressed the clinical utility of the morphological classification of FSGS in real-world scenarios. We aimed to investigate the therapeutic and prognostic significance of the morphological variants of FSGS in a large cohort of adult patients.
This study aimed to determine the relative prevalence, clinicopathologic presentations, and outcomes of the morphological variants of FSGS in a large cohort of adult patients at a single center in Pakistan.
This retrospective study included all consecutive adults (≥ 16 years) with biopsy-proven primary FSGS from January 1995 to December 2017. Studied subjects were treated uniformly with steroids and cyclosporine. The response rates and kidney outcomes were compared between histological variants using appropriate statistical tests. Data were analyzed using SPSS version 22.0. A P-value ≤ 0.05 was considered statistically significant.
The not otherwise specified (NOS) variant was the most common, being found in 185 (53.9%) patients, followed by the TIP variant in 100 (29.1%) patients. Collapsing (COL), cellular, and perihilar variants were seen in 58 (16.9%), 6 (1.5%), and 3 (0.7%) patients, respectively. The response rates were highest in patients with the TIP variant and lowest in those with the COL variant. Kidney outcomes were best in patients with the TIP variant and worst in those with the COL variant. The NOS variant was intermediate.
The morphological variants of FSGS are relevant and should be utilized to inform treatment and prognosis in individual patients. Combining these with other clinicopathological features to refine their predictive value needs to be investigated in future studies.
A holistic approach to disease categorization needs to be developed, which is practical and clinical-friendly.